RB1 (Ab-608) Antibody

What is the RB1 (Ab-608) Antibody and what epitope does it recognize?

The RB1 (Ab-608) Antibody is a rabbit polyclonal antibody that specifically recognizes the region around the serine 608 phosphorylation site of the Retinoblastoma protein (RB1). The antibody is generated using a synthesized peptide derived from human Retinoblastoma protein, specifically in the amino acid range of 581-630, containing the serine 608 residue (Y-L-S-P-V motif) . This antibody is particularly useful for detecting the phosphorylation status of RB1 at serine 608, which is a critical regulatory site affecting RB1 function in cell cycle control and tumor suppression .

What species reactivity does the RB1 (Ab-608) Antibody demonstrate?

The RB1 (Ab-608) Antibody (catalog numbers vary by manufacturer, including CSB-PA036254) demonstrates reactivity with both human and mouse RB1 proteins . Some versions of phospho-specific antibodies targeting the same region (such as catalog # A00039S608) may also show reactivity with rat samples . When designing experiments, it is essential to verify the specific reactivity of your particular antibody lot through validation experiments in your model system before proceeding with extensive studies.

What applications is the RB1 (Ab-608) Antibody validated for?

The RB1 (Ab-608) Antibody has been validated for multiple experimental applications, including:

• Western Blot (WB): Recommended dilution ranges from 1:500 to 1:3000

• Enzyme-Linked Immunosorbent Assay (ELISA): Recommended dilution up to 1:40000 for some versions

• Immunohistochemistry (IHC): Some variants are validated for IHC with dilutions of 1:100-1:300

The specific phospho-RB1 (Ser608) antibody variants may offer additional validated applications such as Immunofluorescence (IF), depending on the manufacturer .

What are the optimal storage conditions for maintaining RB1 (Ab-608) Antibody activity?

For long-term storage, the RB1 (Ab-608) Antibody should be kept at -20°C for up to one year. For frequent use and short-term storage (up to one month), the antibody can be stored at 4°C . It is critical to avoid repeated freeze-thaw cycles, as these can significantly diminish antibody activity and specificity. The antibody is typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide as stabilizers . Aliquoting the antibody upon first thaw is recommended to prevent degradation from multiple freeze-thaw cycles.

What are the recommended protocols for Western blot applications using RB1 (Ab-608) Antibody?

For optimal Western blot results with RB1 (Ab-608) Antibody:

• Prepare protein lysates using standard protocols with phosphatase inhibitors to preserve phosphorylation status

• Load 20-50 μg of total protein per lane

• Separate proteins using 8-10% SDS-PAGE (as RB1 is approximately 106 kDa)

• Transfer to PVDF or nitrocellulose membrane

• Block with 5% BSA in TBST (not milk, which contains phosphatases)

• Dilute primary antibody at 1:500-1:3000 in blocking buffer

• Incubate overnight at 4°C

• Wash 3-5 times with TBST

• Incubate with appropriate HRP-conjugated secondary antibody

• Develop using ECL or similar detection system

This protocol should result in detection of the RB1 protein at approximately 106 kDa, with potential variations due to phosphorylation status .

How should samples be prepared to preserve RB1 phosphorylation status?

To accurately detect RB1 phosphorylation at Ser608, sample preparation is critical:

• Collect cells or tissues quickly to minimize phosphatase activity

• Lyse samples in buffer containing phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate, and phosphatase inhibitor cocktails)

• Maintain samples at cold temperatures (on ice) throughout processing

• Avoid prolonged storage of protein lysates before analysis

• For tissue samples, flash-freeze in liquid nitrogen immediately after collection

• Process samples consistently between experimental conditions to ensure comparable phosphorylation states

This methodology ensures that the phosphorylation state of RB1 at Ser608 is preserved for accurate analysis using the antibody .

How can I validate the specificity of RB1 (Ab-608) Antibody in my experimental system?

To validate antibody specificity:

• Positive controls: Include known RB1-expressing cell lines (e.g., MCF7 or HeLa cells)

• Negative controls: Consider using RB1-knockout or RB1-low expressing cell lines

• Phosphorylation-state controls:

  • Treat samples with lambda phosphatase to remove phosphorylation

  • Use serum-starved cells (hypophosphorylated RB1) versus proliferating cells (hyperphosphorylated RB1)

• Peptide competition assay: Pre-incubate antibody with immunizing peptide before application to demonstrate binding specificity

• Molecular weight verification: Confirm band appears at expected molecular weight (~106 kDa)

• siRNA knockdown: Compare RB1 signal in control versus RB1-knockdown samples

These validation approaches ensure that the observed signals are specific to the RB1 protein and its phosphorylation at Ser608.

What are the common challenges in detecting phospho-RB1 (Ser608) and how can they be addressed?

Common challenges and solutions include:

Particular attention should be paid to preserving phosphorylation status during sample preparation, as RB1 phosphorylation is labile and affected by experimental conditions .

How can I differentiate between signals from phosphorylated versus non-phosphorylated RB1 using this antibody?

The RB1 (Ab-608) Antibody is generated against a non-phosphopeptide derived from the region surrounding serine 608 . To properly differentiate between phosphorylated and non-phosphorylated forms:

• Use parallel phospho-specific (e.g., Phospho-RB1 (Ser608) Antibody, CSB-PA582717) and total RB1 antibodies on identical samples

• Implement phosphatase treatment controls:

  • Split your sample into two portions

  • Treat one portion with lambda phosphatase

  • Compare the signals from treated and untreated samples

• Use cell cycle synchronization:

  • G0/G1 cells (serum-starved) will have predominantly hypophosphorylated RB1

  • S-phase cells will have hyperphosphorylated RB1

• Calculate phospho-to-total RB1 ratios for quantitative assessment

This methodological approach allows for accurate assessment of RB1 phosphorylation status at serine 608 in your experimental system.

What experimental approaches can be used to study the dynamic regulation of RB1 Ser608 phosphorylation?

To study the dynamic regulation of RB1 Ser608 phosphorylation:

• Cell cycle synchronization studies:

  • Synchronize cells at G0/G1 using serum starvation

  • Release into cell cycle and collect samples at defined timepoints

  • Analyze Ser608 phosphorylation relative to cell cycle progression markers

• Kinase inhibition/activation experiments:

  • Treat cells with specific CDK inhibitors (palbociclib for CDK4/6; roscovitine for CDK2)

  • Assess changes in RB1 Ser608 phosphorylation

  • Combine with other phospho-specific antibodies for comprehensive analysis

• Phosphatase regulation studies:

  • Modulate phosphatase activity (e.g., PP1, PP2A) using inhibitors or siRNA

  • Examine effects on RB1 phosphorylation maintenance/turnover

  • Assess calcium signaling effects on RB1 dephosphorylation

• Live-cell imaging approaches:

  • Generate phospho-mimetic or phospho-deficient RB1 mutants

  • Perform fluorescence microscopy to track localization and protein interactions

  • Correlate with cell cycle progression and transcriptional activity

These methodological approaches enable detailed investigation of the regulatory mechanisms controlling RB1 Ser608 phosphorylation in various cellular contexts .

How can the RB1 (Ab-608) Antibody be used to investigate RB1's role in heterochromatin formation and histone methylation?

RB1 plays a direct role in heterochromatin formation and histone methylation regulation . The RB1 (Ab-608) Antibody can be utilized to investigate these functions through:

• Chromatin Immunoprecipitation (ChIP) assays:

  • Use the antibody to immunoprecipitate RB1-bound chromatin regions

  • Analyze association with specific promoters, particularly E2F target genes

  • Correlate RB1 binding with repressive histone marks

• Co-immunoprecipitation (Co-IP) experiments:

  • Precipitate RB1 using the antibody and analyze interactions with:

    • Histone methyltransferases (SUV39H1, KMT5B, KMT5C)

    • E2F family members

    • HDAC complex components

  • Compare interactions in different phosphorylation states

• Sequential ChIP (Re-ChIP) approach:

  • Perform initial ChIP with RB1 antibody

  • Re-immunoprecipitate with antibodies against histone methylation marks

  • Map co-occupancy of RB1 and specific histone modifications

• Immunofluorescence co-localization:

  • Use dual staining with RB1 antibody and heterochromatin markers

  • Analyze nuclear distribution patterns

  • Correlate with cell cycle stage and transcriptional activity

These methodologies enable researchers to investigate how RB1 phosphorylation status at Ser608 influences its epigenetic regulatory functions and heterochromatin maintenance activities .

How does the RB1 (Ab-608) Antibody compare to other RB1 phospho-specific antibodies?

A comparative analysis of commonly used RB1 phospho-specific antibodies reveals:

Using combinations of these antibodies provides a comprehensive view of RB1 phosphorylation status and can reveal the sequential nature of RB1 regulation throughout the cell cycle.

What cell models and experimental systems are most appropriate for studying RB1 phosphorylation at Ser608?

The most suitable experimental systems for studying RB1 Ser608 phosphorylation include:

• Cell line selection considerations:

  • RB1-proficient cancer cell lines (MCF7, A549, HCT116)

  • Primary human or mouse fibroblasts

  • Pairs of RB1-positive and RB1-negative cell lines for specificity controls

  • Cell lines with well-characterized cell cycle regulation

• Tissue models:

  • Normal versus tumor tissue pairs

  • Developmental stage-specific tissues

  • Proliferating versus differentiated tissues

• Inducible systems:

  • Tetracycline-regulated RB1 expression

  • Degron-tagged RB1 for rapid protein depletion

  • CDK activity modulation systems

• Genetic models:

  • RB1 knockout/knockin models

  • Phospho-site mutant expression systems

  • CRISPR-engineered cell lines with specific RB1 mutations

These experimental systems should be selected based on the specific research question regarding RB1 Ser608 phosphorylation and its biological consequences .

How can RB1 (Ab-608) Antibody be utilized in cancer research and therapeutic development?

RB1 dysfunction is central to many cancer types, making the RB1 (Ab-608) Antibody valuable for cancer research:

• Biomarker development applications:

  • Assess RB1 phosphorylation status in patient-derived samples

  • Correlate with response to CDK inhibitors (palbociclib, ribociclib, abemaciclib)

  • Monitor treatment efficacy through changes in RB1 phosphorylation

• Drug screening approaches:

  • High-throughput screening for compounds affecting RB1 phosphorylation

  • Target validation for novel CDK inhibitors

  • Combination therapy evaluation based on RB1 pathway activity

• Resistance mechanism studies:

  • Investigate altered RB1 phosphorylation in drug-resistant cells

  • Identify compensatory pathways when RB1 function is compromised

  • Discover bypass mechanisms in RB1-deficient tumors

• Therapeutic response prediction:

  • Develop assays to predict CDK inhibitor sensitivity based on RB1 phosphorylation patterns

  • Correlate Ser608 phosphorylation with other CDK targets

  • Establish predictive models for personalized therapy selection

These applications leverage the ability of the antibody to monitor a critical regulatory event in the cell cycle control pathway that is frequently disrupted in cancer .

What are the methodological considerations for multiplexed analysis of RB1 phosphorylation states?

For comprehensive multiplexed analysis of RB1 phosphorylation:

• Multi-parameter flow cytometry:

  • Combine RB1 phospho-antibodies with cell cycle markers (Ki67, PCNA)

  • Perform intracellular staining with validated protocols

  • Analyze at single-cell level to detect heterogeneity

• Multiplexed Western blotting:

  • Use fluorescent secondary antibodies with different wavelengths

  • Strip and reprobe membranes sequentially with different phospho-specific antibodies

  • Normalize to total RB1 for accurate quantification

• Mass spectrometry approaches:

  • Immunoprecipitate RB1 using the antibody

  • Perform phospho-peptide enrichment

  • Quantify multiple phosphorylation sites simultaneously

  • Compare relative abundance of different phospho-forms

• Imaging techniques:

  • Multi-color immunofluorescence with different phospho-specific antibodies

  • Quantitative image analysis of nuclear versus cytoplasmic distribution

  • Co-localization with cell cycle markers

These methodological approaches enable researchers to obtain a comprehensive view of RB1 phosphorylation dynamics across multiple regulatory sites simultaneously .